Cardiomyopathy Trial, Recruiting (NCT06793020)

Cardiomyopathy Trial, Recruiting NCT06793020 Sponsor: Vilnius University Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06793020 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with sepsis (a serious response to infection) based on specific medical scoring criteria, meaning they have a suspected or confirmed infection along with signs that their organs are under stress
People who have septic shock, which means their sepsis has progressed to the point where they need medication to keep their blood pressure at a safe level, and their blood shows signs of poor circulation
People who require a specific blood pressure-supporting medication called norepinephrine at a dose above a certain level to maintain stable blood pressure
People who have given their written agreement to take part in the trial

Who may not be able to join:

People who are under 18 years of age
People who have a serious heart condition that is not under control, including shock caused by a failing heart, a heart defect present from birth, or heart failure at the most severe level (where symptoms occur even at rest)
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06793020

Sponsor: Vilnius University

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

More information: https://clinicaltrials.gov/study/NCT06793020

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with sepsis (a serious response to infection) based on specific medical scoring criteria, meaning they have a suspected or confirmed infection along with signs that their organs are under stress
People who have septic shock, which means their sepsis has progressed to the point where they need medication to keep their blood pressure at a safe level, and their blood shows signs of poor circulation
People who require a specific blood pressure-supporting medication called norepinephrine at a dose above a certain level to maintain stable blood pressure
People who have given their written agreement to take part in the trial

Who may not be able to join:

People who are under 18 years of age
People who have a serious heart condition that is not under control, including shock caused by a failing heart, a heart defect present from birth, or heart failure at the most severe level (where symptoms occur even at rest)
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vilnius University

Registry

ClinicalTrials.gov

Start date

17 March 2024

Est. completion

1 March 2028

Where this trial is recruiting

🇱🇹 Lithuania 🇵🇱 Poland

Primary endpoints

Incidence of septic cardiomyopathy when comparing a new clinical-echocardiographic model with the standard diagnostic method (left ventricular ejection fraction).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov